Amarillo Biosciences to Explore Low-Dose Oral Interferon Therapeutics in China as a Line of Defense Against Coronavirus and Other Viral Indications

The threat from the novel coronavirus outbreak has recently prompted the China National Health Commission to formally recommend the use of anti-AIDS drugs and inhalable interferon.